Methods of bioengineering internal anal sphincter constructs

Patent metadata

Field	Value
Publication number	US-2022016316-A1
Application number	US-201917294312-A
Country	US
Kind code	A1
Filing date	Nov 14, 2019
Priority date	Nov 16, 2018
Publication date	Jan 20, 2022
Grant date	—

Abstract

The present disclosure provides methods of bioengineering sphincters having autologous smooth muscle cells isolated from human internal anal sphincter and autologous enteric neurospheres (neural progenitor cells) isolated from human small intestine (jejunum). The isolated neural progenitor cells and smooth muscle cells are co -cultured using dual layered hydrogels and allowed to form circular, intrinsically innervated internal anal sphincter constructs. Such innervated internal anal sphincter constructs, bioengineered internal anal sphincter constructs are useful as additive implants in the treatment of fecal incontinence.

First claim

What is claimed is:

1 . A method of generating an innervated internal anal sphincter construct, comprising:
obtaining an anorectum tissue cell biopsy from a subject; obtaining an intestinal tissue cell biopsy from the subject; isolating smooth muscle cells from the anorectum tissue cell biopsy; isolating neural progenitor cells from the intestinal tissue cell biopsy; seeding a multi-layer gel matrix on a mold, comprising at least a one gel layer of isolated smooth muscle cells and at least another gel layer of isolated neural progenitor cells in contact with one another, wherein the matrix is seeded in a substantially circular shape; and contacting the multi-layer gel matrix with a differentiation media to induce differentiation of the neural progenitor cells, thereby forming the innervated construct having directionally oriented smooth muscle cells.

2 . The method of claim 1 , wherein the step of obtaining the anorectum tissue cell biopsy further comprises a step of obtaining the biopsy from the subject's internal anal sphincter tissue.

3 . The method of claim 1 , wherein the step of obtaining the intestinal tissue cell biopsy further comprises a step of obtaining the biopsy from the subject's jejunal small intestine tissue.

4 . The method of claim 1 , wherein at least one of the steps of obtaining the anorectum tissue cell biopsy and obtaining the intestinal tissue cell biopsy is performed laparoscopically.

5 . The method of claim 1 , wherein the step of isolating smooth muscle cells from the anorectum tissue cell biopsy comprises a step of mechanically disaggregating the anorectum tissue cell biopsy.

6 . The method of claim 1 , wherein the step of isolating smooth muscle cells from the anorectum tissue cell biopsy comprises enzymatically digesting the biopsied anorectal tissue by applying a digesting medium.

7 . The method of claim 6 , wherein the digesting medium comprises a collagenase and optionally further comprises applying at least one type 2 collagenase such as Collagenase DE, and Collagenase HA or Vitacyte®, or another protease such as Distase or BP protease, or combinations thereof.

8 . The method of claim 1 , wherein the step of isolating smooth muscle cells from the anorectum tissue cell biopsy further comprises a step of suspending disaggregated digested smooth muscle cells in a smooth muscle cell growth medium.

9 . The method of claim 8 , wherein the smooth muscle cell growth medium comprises a Smooth Muscle Basal Medium optionally supplemented with fetal bovine serum, L-glutamine and/or an antibiotic/antimycotic agent.

10 . The method of claim 1 , wherein the step of isolating neural progenitor cells from the intestinal tissue cell biopsy comprises a step of mechanically disaggregating the intestinal tissue cell biopsy.

11 . The method of claim 1 , wherein the step of isolating neural progenitor cells from the intestinal tissue cell biopsy comprises enzymatically digesting the intestinal tissue cell biopsy with a digesting medium.

12 . The method of claim 11 , wherein the digesting medium comprises a collagenase such as Collagenase DE, Collagenase HA or Vitacyte®, or another protease such as Distase or BP protease, or combinations thereof.

13 . The method of claim 1 wherein the step of isolating neural progenitor cells from the intestinal tissue cell biopsy comprises a step of suspending the isolated neural progenitor cells in a neural growth medium.

14 . The method of claim 13 , wherein the neural growth medium comprises a neural basal medium, optionally supplemented with an N-2 supplement, one or more growth factors, L-Glutamine, and/or an antibiotic/antimycotic agent.

15 . The method of claim 1 , wherein prior to seeding the multi-layer gel matrix, the method further comprises a step of culturing the isolated smooth muscle cells until a number of smooth muscle cells reaches at least one million cells, or optionally more than 10 million cells.

16 . The method of claim 1 , wherein prior to seeding the multi-layer gel matrix, the method further comprises a step of preparing at least one gel layer of isolated smooth muscle cells by suspending the isolated smooth muscle cells in a gel matrix material comprising collagen.

17 . The method of claim 1 , wherein prior to seeding the multi-layer gel matrix, the method further comprises a step of culturing the isolated neural progenitor cells until a number of neural progenitor cells reaches at least one million cells, or optionally more than five million cells.

18 . The method of claim 1 , wherein prior to seeding the multi-layer gel matrix, the method further comprises a step of preparing at least one gel layer of isolated neural progenitor cells by suspending the isolated neuronal progenitor cells in a gel matrix material comprising collagen and laminin.

19 . The method of claim 1 , wherein the mold comprises a central post and the step of seeding comprises depositing the gel layers around the central post.

20 . The method of claim 1 , further comprising a step of removing the construct from the mold.

Assignees

• Univ Wake Forest Health Sciences

Inventors

• Bitar Khalil

Classifications

• C12N2501/115

  Basic fibroblast growth factor (bFGF, FGF-2) · CPC title

• C12N5/0697

  Artificial constructs associating cells of different lineages, e.g. tissue equivalents (blood vessels C12N5/0691) · CPC title

• C12N2501/11

  Epidermal growth factor [EGF] · CPC title

• C12N2533/54

  Collagen; Gelatin · CPC title

• C12N5/0619

  Neurons · CPC title